Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors

NCT00227617 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00227617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00227617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors
Lead sponsor
University of California, San Francisco
Phase
Phase 2/3
Overall status
Terminated
Start date
June 8, 2005
Completion date
February 29, 2016
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal carcinoid tumor, islet cell tumor, lung cancer, neoplastic syndrome, neuroendocrine tumor